Ovarian Neoplasms: all 2,757 studies
Page 22 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian CancerSuspendedNCT02093871Phase 1
- Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT02092363Phase 1
- H.O.P.E: Helping Ovarian Cancer Patients CopeCompletedNCT02090582Not applicable
- Protocol to Allow Continued Access of Ficlatuzumab to P05538 PatientNo longer availableNCT02090127
- Feasibility of Lifestyle Intervention in BRCA1/2 Mutation CarriersCompletedNCT02087592Not applicable
- Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical TechniquesCompletedNCT02086370Not applicable
- LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian CarcinomaWithdrawnNCT02083536Phase 1
- A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT02081495Phase 1
- Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid TumorCompletedNCT02069158Phase 1
- Blood Collection From People With Ovarian CancerCompletedNCT02063464
- PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian CancerTerminatedNCT02055690Phase 1/2
- Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)CompletedNCT02054351Phase 1
- Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian CancerActive, not recruitingNCT02043158
- Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02042430Early Phase 1
- Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaCompletedNCT02039388Not applicable
- Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian CarcinomasStatus unknownNCT02033616Phase 2
- A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid TumorsCompletedNCT02033551Phase 1
- Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer PatientsCompletedNCT02028117Phase 1
- A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian CancerCompletedNCT02026921Phase 2
- Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian CancerCompletedNCT02022917Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer PatientsCompletedNCT02019524Phase 1
- Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer OriginWithdrawnNCT02017678Phase 2
- Development of Immunological Assays for the Evaluation of Tumor Antigen Specific ImmunityCompletedNCT02016833
- A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerCompletedNCT02015416Phase 1
- Long Term Prevention of Nausea and Vomiting in Gynecologic LaparoscopyStatus unknownNCT02011659Phase 3
- A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid TumorsCompletedNCT02009631Phase 1
- EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian CancerCompletedNCT02001272Phase 2
- EC17 for Intraoperative Imaging in Occult Ovarian CancerCompletedNCT02000778Phase 1
- A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)TerminatedNCT01991210Phase 2
- Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian CancerCompletedNCT01982500
- Predictive Clinical and Biological Parameters in Gynecological CancerActive, not recruitingNCT01977274Not applicable
- Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal CancerActive, not recruitingNCT01970722Phase 1
- LDE225 and Paclitaxel in Solid TumorsCompletedNCT01954355Phase 1
- Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.CompletedNCT01953107Phase 4
- Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian CancerCompletedNCT01940172Phase 1
- An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerCompletedNCT01932125Phase 4
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer SurvivorsCompletedNCT01929720Not applicable
- Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian CancerWithdrawnNCT01927393Not applicable
- Prophylactic Salpingectomy With Delayed OophorectomyActive, not recruitingNCT01907789Not applicable
- Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
- Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian CancerStatus unknownNCT01889615
- Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian ReserveStatus unknownNCT01888159Not applicable
- Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian CancerTerminatedNCT01881451
- Tai-chi / Qi-gong in Patients With Patients With Gynecological MalignanciesWithdrawnNCT01880996Phase 1/2
- An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian CancerCompletedNCT01869400
- An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)CompletedNCT01863693
- A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid TumorsCompletedNCT01853306Phase 1
- A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian CancerStatus unknownNCT01851746
- Prevention of Ovarian Cancer in Women Participating in MammographyCompletedNCT01851109Not applicable
- Neoadjuvant Therapy in Advanced Ovarian Cancer With AvastinTerminatedNCT01847677Phase 2
- Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion ChemotherapyStatus unknownNCT01838538Phase 2
- Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian CancerCompletedNCT01837251Phase 3
- Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma PatientsCompletedNCT01834469Phase 1/2
- First Line Ovarian Cancer Treatment - Cohort StudyCompletedNCT01832415
- 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer PatientsCompletedNCT01832116Phase 1
- Sunitinib® in Patients With Recurrent Ovarian Clear Cell CarcinomaCompletedNCT01824615Phase 2
- A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis IndexStatus unknownNCT01823731
- Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving PaclitaxelCompletedNCT01821833Not applicable
- Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian CancerCompletedNCT01815528Phase 2
- A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT01815294Phase 1
- STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian CancerCompletedNCT01810874Not applicable
- Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian CancerCompletedNCT01809379Phase 2
- Bevacizumab Beyond Progression in Platinum Sensitive Ovarian CancerStatus unknownNCT01802749Phase 3
- BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian CancerCompletedNCT01788995
- A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and MucusCompletedNCT01787656
- Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian CancerCompletedNCT01778803Phase 1
- Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian CancerStatus unknownNCT01772979Phase 2
- Oxford Ovarian Cancer Predict Chemotherapy Response 01Status unknownNCT01770535
- Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian CancerCompletedNCT01768156Not applicable
- 18F-CP18 Imaging Studies for Cancer Treatment With BirinapantWithdrawnNCT01766622Phase 2
- Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
- Cabazitaxel in Platinum Refractory Ovarian CancerTerminatedNCT01747239Phase 2
- The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility StudyTerminatedNCT01743547Not applicable
- EURAD-MR Classification : European Multicenter StudyStatus unknownNCT01738789
- Elecsys HE4 Chinese Reference Value StudyCompletedNCT01738269
- Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian CancerCompletedNCT01735071Phase 2
- Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)WithdrawnNCT01732432
- LYmphadenectomy After NeoAdjuvant ChemotherapyStatus unknownNCT01724944Phase 1/2
- Phase I Platinum Based Chemotherapy Plus IndomethacinCompletedNCT01719926Phase 1
- A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian CancerStatus unknownNCT01715168Phase 1
- Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line TherapyCompletedNCT01709487Phase 1/2
- Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With BevacizumabStatus unknownNCT01706120Phase 4
- Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the PlatinumCompletedNCT01705158Phase 1/2
- International Ovarian Tumour Analysis (IOTA) Phase 5Status unknownNCT01698632
- Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA StatusCompletedNCT01690598Phase 1/2
- PTX-200 and Carboplatin in Ovarian CancerTerminatedNCT01690468Phase 1/2
- Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial CarcinomaCompletedNCT01689714Phase 2
- Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer PatientsCompletedNCT01689636Phase 1
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial CancerCompletedNCT01686256Phase 1
- A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line ChemotherapyTerminatedNCT01685255Phase 2
- Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian CystectomyCompletedNCT01683877Not applicable
- Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian CancerStatus unknownNCT01680575
- First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian CancerCompletedNCT01669226Phase 2
- Olaparib for Patients With Recurrent BRCA Deficient Ovarian CancerWithdrawnNCT01661868Phase 2
- Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian CancerCompletedNCT01657747Not applicable
- A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic CancerCompletedNCT01654458Not applicable
- ICON8: Weekly Chemotherapy in Ovarian CancerStatus unknownNCT01654146Phase 3
- CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal CancerCompletedNCT01652079Phase 2